Member News
-
Valeo Pharma to Host First Quarter 2022 Results Conference Call / Webcast and Attend the 8th Annual AlphaNorth Capital Conference
March 17, 2022 (Source) – Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo” or the “Company”), a…
-
Valeo Pharma Reports Record Annual Revenues for Fiscal 2021
February 28, 2022 (Source) — Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo” or the “Company”), a…
-
Valeo Pharma Obtains Public Reimbursement for Enerzair® Breezhaler® and Atectura® Breezhaler® in Ontario, Manitoba and New Brunswick
Atectura and Enerzair also now reimbursed by the Non-Insured Health Benefits (“NIHB”) program of Indigenous Services Canada and Veteran…
-
Valeo Pharma To Host Fourth Quarter And Year-End 2021 Results Conference Call / Webcast
February 21, 2022 (Source) — Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo” or the “Company”), a…
-
Valeo Pharma’s Hesperco™ Now Available at Loblaws, Hesperidin Covid-19 Clinical Trial Results Submitted for Publication
Hesperco now available in approximately 300 stores under the Loblaws banners Clinical study yields encouraging results that hesperidin…
-
Valeo Pharma Obtains Public Reimbursement for Enerzair® Breezhaler® and Atectura® Breezhaler® in Quebec and Nova Scotia
Public reimbursement now includes Alberta, Quebec and Nova Scotia, representing approximately 37% of the Canadian population. More than…
-
Valeo Pharma Closes Previously Announced Upsized $15 Million Bought Deal Private Placement and Concurrent $10 Million Private Placement from Investissement Quebec
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY…
-
Valeo Pharma Announces Upsize of Previously Announced Bought Deal Private Placement of Convertible Debentures to $15 Million With Concurrent $10 Million Private Placement From Investissement Quebec
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY…
-
Valeo Pharma Announces $10 Million Bought Deal Private Placement of Convertible Debentures With Concurrent $10 Million Private Placement From Investissement Quebec
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY…
-
Valeo Pharma Obtains Public Reimbursement for Redesca™ and Redesca Hp™ in Quebec
Public reimbursement coverage reaches 9 Provinces in Canada Canadian private health plan coverage now exceeding 90% November 15, 2021…
